7 Effects of Berberine Hydrochloride

Berberine hydrochloride tablets, commonly known as "Huang Lian Su", are over-the-counter antidiarrheal medications in China. They are a major alkaloid found in the rhizome of the Ranunculaceae plant Coptis Chinensis, and can be extracted from Berberis Aristata, Phellodendron chinense, or Gnaphalium affine. Berberine hydrochloride tablets have various clinical applications, primarily including the following: 

(A) Digestive System Diseases 

1. Intestinal infections: such as gastroenteritis, diarrhea, dysentery, etc. 

Interpretation: Berberine hydrochloride has an inhibitory effect on a variety of Gram-positive and Gram-negative bacteria, especially on a variety of pathogenic bacteria such as hemolytic streptococci and Staphylococcus aureus. 

2. Peptic ulcer: It has an inhibitory effect on Helicobacter pylori, which can reduce the toxicity of Helicobacter pylori infection to cells, thereby assisting in the treatment of peptic ulcer. 

Explanation: The mechanism of action of berberine hydrochloride tablets in treating peptic ulcers mainly includes antibacterial (anti-Helicobacter pylori), anti-inflammatory, gastric mucosal protection, inhibition of gastric acid secretion, and improvement of gastrointestinal function. Clinically, it is often used in combination with other drugs (such as proton pump inhibitors and antibiotics) to improve the therapeutic effect. 

3. Chronic cholecystitis: Combined treatment with trisulfide tablets for chronic cholecystitis in the elderly can reduce the level of inflammatory factors in the patient's serum and improve clinical symptoms. 

Interpretation: Clinical studies have shown that the combination of berberine hydrochloride tablets and anethole trisulfide tablets is significantly more effective than anethole trisulfide tablets alone in treating chronic cholecystitis in the elderly. Patients' clinical symptoms are significantly improved and the levels of inflammatory factors are significantly reduced.

4. Ulcerative colitis: Combining mesalazine or sulfasalazine with other drugs to treat ulcerative colitis can significantly reduce the inflammatory response, improve clinical symptoms, and promote the recovery of intestinal mucosal barrier function. 

Interpretation: Berberine hydrochloride intervenes in the pathogenesis of ulcerative colitis through multiple targets and pathways, and has anti-inflammatory, immunomodulatory and intestinal protective effects, making it a promising adjuvant therapy drug. 

(B) Metabolic Diseases 

1. Type 1 and 2 diabetes: Blood sugar levels can be controlled by using it alone or in combination with Western medicines (such as metformin, glipizide, etc.). 

Interpretation: Berberine hydrochloride tablets play a positive role in the treatment of type 2 diabetes through multiple mechanisms, including improving insulin resistance, lowering blood sugar, regulating blood lipids, anti-inflammatory and antioxidant effects, and regulating gut microbiota. Its efficacy is definite, its safety is good, and it is particularly suitable for combination therapy strategies. 

2. Hyperlipidemia: It can effectively regulate blood lipids, reduce the levels of total cholesterol (TC) and triglycerides (TG) in plasma, and increase high-density lipoprotein cholesterol (HDL-C). When used in combination with statins (such as atorvastatin and rosuvastatin), the lipid-lowering effect can be further enhanced.  

Interpretation: Clinical studies show that berberine can lower total cholesterol, LDL cholesterol, and triglyceride levels, with reductions of up to 20–50 mg/dL and 25–55 mg/dL, respectively. Therefore, berberine hydrochloride tablets have a good lipid-lowering effect and are especially suitable for patients who cannot tolerate statins. 

3. Diabetic peripheral neuropathy: Inhibits aldose reductase activation, reduces sorbitol accumulation, and protects nerve function. 

Interpretation: Berberine hydrochloride improves the neural structure and function of diabetic peripheral neuropathy through a quadruple mechanism of "anti-inflammatory + antioxidant + anti-apoptosis + metabolic regulation", which has scientific basis and clinical prospects as an adjunct therapy.